Careers  |  Sign In  |  Register  |   Twitter

AHA Scientific Sessions – Meetings in Minutes – Day 4

Coverage of the American Heart Association Scientific Sessions 2010

Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 4.

Our fourth and final daily wrap-up features highlights from the key late breaking trials, and some of the most interesting abstracts presented at the meeting.

Key Late-Breaking Clinical Trials Covered:

• ASCOT Trial – Testing CRP at baseline and on-treatment as an independent predictor of cardiovascular outcomes

• DEFINE Trial – Determining the efficacy and tolerability of CETP inhibition with anacetrapib

• ASSERT Study – Results of the first major clinical trial of an oral agent inducing ApoA-1 synthesis

• SIMPLICITY HTN-2 Study – International, multicenter, prospective, randomized, controlled trial of endovascular selective renal sympathetic denervation for the treatment of hypertension

Highlighted in the video is expert commentary from leaders in cardiology including:

• Donald Lloyd-Jones, MD, ScM, FACC, FAHA – Chair of Preventive Medicine, Northwestern University Feinberg School of Medicine

• Christopher P. Cannon, MD – Associate Professor of Medicine, Harvard Medical School

• Eliot A. Brinton, MD, FAHA – Director of the Metabolism Section of Cardiovascular Genetics, University of Utah School of Medicine

• Murray Esler, MD – Associate Professor, Baker Heart Research Institute

• Margaret Fang, MD, MPH – Medical Director, UCSF Anticoagulation Clinic

• John A. Ryan, MD, FACS – Cardiology Fellow, University of Chicago Hospitals

Check back for more in-depth coverage of AHA Scientific Sessions 2010 in the coming days.